MDM2 and neoplasm: Since a smaller subset of high-risk tumours exhibit a homozygous CKDN2A deletion leading to absence of p14 and thereby excessive MDM2 activity, this could comprise an alternative mechanism of p53 inactivation in these tumours [41].